Cardiac allograft vasculopathy: A review
暂无分享,去创建一个
Sunil V. Rao | A. Kirtane | Z. Ali | Michael S. Lee | C. Patel | W. Fearon | Amisha J Patel | Rigved V Tadwalkar | S. Rao
[1] K. Park,et al. Role of Percutaneous Coronary Intervention in the Treatment of Cardiac Allograft Vasculopathy. , 2018, The American journal of cardiology.
[2] Akshay S. Desai,et al. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy , 2018, European heart journal.
[3] W. Fearon,et al. Invasive Assessment of the Coronary Microvasculature: The Index of Microcirculatory Resistance , 2017, Circulation. Cardiovascular interventions.
[4] B. Bergmark,et al. Early aspirin use and the development of cardiac allograft vasculopathy. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[5] A. Yeung,et al. Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation. , 2017, Journal of the American College of Cardiology.
[6] A. Yeung,et al. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy. , 2016, Journal of the American College of Cardiology.
[7] A. Yeung,et al. Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation , 2016, Circulation.
[8] A. Yeung,et al. Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation. , 2015, JACC. Heart failure.
[9] D. Briscoe,et al. Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection , 2015, Transplantation.
[10] A. Yeung,et al. Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] J. Aranda,et al. Drug-eluting stents may not reduce target lesion revascularization in cardiac allograft vasculopathy. , 2014, Journal of interventional cardiology.
[12] J. Stypmann,et al. Everolimus in Heart Transplantation: An Update , 2013, Journal of transplantation.
[13] J. Pober,et al. Alloantibody and Complement Promote T Cell–Mediated Cardiac Allograft Vasculopathy Through Noncanonical Nuclear Factor-&kgr;B Signaling in Endothelial Cells , 2013, Circulation.
[14] F. Fallani,et al. Differential Effect of Everolimus on Progression of Early and Late Cardiac Allograft Vasculopathy in Current Clinical Practice , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] R. Rodeheffer,et al. Combined Heart and Liver Transplant Attenuates Cardiac Allograft Vasculopathy Compared with Isolated Heart Transplantation , 2013, Transplantation.
[16] B. Meiser,et al. Ten-Year Results of a Randomized Trial Comparing Tacrolimus Versus Cyclosporine A in Combination With Mycophenolate Mofetil After Heart Transplantation , 2013, Transplantation.
[17] F. Ruschitzka,et al. Allograft vasculopathy vs. coronary artery disease: comparison by optical coherence tomography. , 2013, European heart journal.
[18] A. Pavie,et al. Multislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patients. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[19] Á. Cequier,et al. Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients. , 2012, Transplantation proceedings.
[20] C. Becker,et al. Detection of significant coronary artery stenosis with cardiac dual‐source computed tomography angiography in heart transplant recipients , 2012, Transplant international : official journal of the European Society for Organ Transplantation.
[21] K. Wood,et al. Inflammatory Ly-6Chi monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients , 2012, Atherosclerosis.
[22] Shaosong Zhang,et al. OCT assessment of allograft vasculopathy in heart transplant recipients. , 2012, JACC. Cardiovascular imaging.
[23] D. Thompson,et al. Single photon emission computed tomography myocardial perfusion imaging to detect cardiac allograft vasculopathy. , 2012, European heart journal cardiovascular Imaging.
[24] K. Otsuka,et al. Magnetic resonance assessment of left ventricular diastolic dysfunction for detecting cardiac allograft vasculopathy in recipients of heart transplants , 2012, The International Journal of Cardiovascular Imaging.
[25] G. Laufer,et al. Low Serum IGF-1 Is a Risk Factor for Cardiac Allograft Vasculopathy in Cardiac Transplant Recipients , 2012, Transplantation.
[26] R. Rodeheffer,et al. Sirolimus as Primary Immunosuppression Attenuates Allograft Vasculopathy With Improved Late Survival and Decreased Cardiac Events After Cardiac Transplantation , 2012, Circulation.
[27] Akshay S. Desai,et al. Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-year follow-up from a randomized, controlled study. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[28] M. Fishbein,et al. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[29] A. Yeung,et al. Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy. , 2011, The American journal of cardiology.
[30] L. Merello,et al. Prevalence of cardiac allograft vasculopathy assessed with coronary angiography versus coronary vascular ultrasound and virtual histology. , 2011, Transplantation proceedings.
[31] T. Larson,et al. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. , 2011, Transplantation proceedings.
[32] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[33] Clive Lewis,et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[34] R. Starling,et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[35] Yen-Wen Wu,et al. PET Assessment of Myocardial Perfusion Reserve Inversely Correlates with Intravascular Ultrasound Findings in Angiographically Normal Cardiac Transplant Recipients , 2010, Journal of Nuclear Medicine.
[36] K. Otsuka,et al. Evaluation of cardiac allograft vasculopathy by multidetector computed tomography and whole-heart magnetic resonance coronary angiography. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[37] S. Achenbach,et al. Comparison of dual source computed tomography versus intravascular ultrasound for evaluation of coronary arteries at least one year after cardiac transplantation. , 2009, The American journal of cardiology.
[38] N. Osman,et al. Strain‐Encoded Cardiac Magnetic Resonance for the Evaluation of Chronic Allograft Vasculopathy in Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] A. Lerman,et al. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. , 2009, Journal of the American College of Cardiology.
[40] J. Tobis,et al. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy. , 2008, JACC. Cardiovascular interventions.
[41] H. Katus,et al. Prevalence of different gadolinium enhancement patterns in patients after heart transplantation. , 2008, Journal of the American College of Cardiology.
[42] A. Yeung,et al. Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. , 2008, American heart journal.
[43] A. Stadler,et al. Detection of high-grade stenoses with multislice computed tomography in heart transplant patients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[44] U. Siebert,et al. Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[45] P. Nadziakiewicz,et al. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease. , 2007, Transplantation proceedings.
[46] J. Nelson,et al. Acceleration of allograft failure by cytomegalovirus. , 2007, Current opinion in immunology.
[47] N. Bogot,et al. Cardiac CT of the transplanted heart: indications, technique, appearance, and complications. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.
[48] M. Kass,et al. Diagnosis of graft coronary artery disease , 2007, Current opinion in cardiology.
[49] A. Yeung,et al. Changes in Coronary Arterial Dimensions Early After Cardiac Transplantation , 2007, Transplantation.
[50] S. Iyengar,et al. Detection of coronary artery disease in orthotopic heart transplant recipients with 64-detector row computed tomography angiography. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[51] D. Holmes,et al. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. , 2006, Transplantation.
[52] B. McManus,et al. Allograft Vasculopathy Versus Atherosclerosis , 2006, Circulation research.
[53] Shawn A. Gregory,et al. Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. , 2006, The American journal of cardiology.
[54] Mario J. Garcia,et al. Detection of transplant coronary artery disease using multidetector computed tomography with adaptative multisegment reconstruction. , 2006, Journal of the American College of Cardiology.
[55] H. Ly,et al. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. , 2006, Journal of the American College of Cardiology.
[56] J. Tobis,et al. Vascular remodelling after cardiac transplantation: a 3-year serial intravascular ultrasound study. , 2006, European heart journal.
[57] H. Eisen. Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[58] A. Yeung,et al. Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[59] J. Tobis,et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. , 2006, Journal of the American College of Cardiology.
[60] G. Ewald,et al. Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1‐Year Report , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[61] S. Hunt,et al. Wound Healing Complications with De Novo Sirolimus Versus Mycophenolate Mofetil‐Based Regimen in Cardiac Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[62] L. Yeatman,et al. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[63] M. Oz,et al. A decade experience of cardiac retransplantation in adult recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[64] P. Tsao,et al. Dimethylarginine Dimethylaminohydrolase Overexpression Suppresses Graft Coronary Artery Disease , 2005, Circulation.
[65] R. Colvin,et al. NK Cells Can Trigger Allograft Vasculopathy: The Role of Hybrid Resistance in Solid Organ Allografts1 , 2005, The Journal of Immunology.
[66] W. Mahle,et al. Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing. , 2005, The Journal of thoracic and cardiovascular surgery.
[67] N. Smedira,et al. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[68] Michael Jerosch-Herold,et al. Cardiac magnetic resonance perfusion imaging identifies transplant arteriopathy by a reduced endomyocardial resting perfusion. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[69] C. Marboe,et al. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[70] D. Mancini,et al. Anti-Human Leukocyte Antigen Antibodies are Associated with Restenosis after Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy , 2005, Transplantation.
[71] J. Paul,et al. Coronary Stenosis Detection by 16-Slice Computed Tomography in Heart Transplant Patients: Comparison With Conventional Angiography and Impact on Clinical Management , 2005 .
[72] A. Yeung,et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. , 2005, Journal of the American College of Cardiology.
[73] D. Renlund,et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[74] D. Renlund,et al. Percutaneous coronary interventions with stents in cardiac transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[75] J. Kobashigawa. Statins and cardiac allograft vasculopathy after heart transplantation. , 2004, Seminars in vascular medicine.
[76] F. Dobbels,et al. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[77] P. Macdonald,et al. Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years: A Randomized Clinical Trial , 2004, Circulation.
[78] B. Meiser,et al. Cytomegalovirus Infection in Heart Transplant Recipients Is Associated With Impaired Endothelial Function , 2004, Circulation.
[79] B. Meiser,et al. Tacrolimus or Cyclosporine: Which Is the Better Partner for Mycophenolate Mofetil in Heart Transplant Recipients? , 2004, Transplantation.
[80] R. Benza,et al. Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience. , 2004, Journal of the American College of Cardiology.
[81] M. Mehra,et al. Metaanalysis of statins and survival in de novo cardiac transplantation. , 2004, Transplantation proceedings.
[82] E. Tuzcu,et al. Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease. , 2004, Journal of the American College of Cardiology.
[83] M. Yacoub,et al. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. , 2004, Vascular pharmacology.
[84] S. Hunt,et al. Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease. , 2004, Journal of the American College of Cardiology.
[85] Eva K. Lee,et al. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[86] A. Yeung,et al. Simultaneous Assessment of Fractional and Coronary Flow Reserves in Cardiac Transplant Recipients: Physiologic Investigation for Transplant Arteriopathy (PITA Study) , 2003, Circulation.
[87] E. Tuzcu,et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. , 2003, The New England journal of medicine.
[88] J. Almendral,et al. Results of percutaneous revascularization in cardiac allograft vascular disease. , 2003, Transplantation proceedings.
[89] D. Burkhoff,et al. Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy , 2003, Circulation.
[90] L. V. von Segesser,et al. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. , 2003, European heart journal.
[91] M. Nicholson,et al. Rapamycin inhibits vascular remodeling in an experimental model of allograft vasculopathy and attenuates associated changes in fibrosis-associated gene expression. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[92] M. Mehra,et al. TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit? , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[93] K. Wenke,et al. Heart failure/transplant: abstractSimvastatin initiated early after heart transplantation: 8-year prospective experience☆ , 2003 .
[94] J. Steinke,et al. 2. Cytokines and chemokines. , 2003, The Journal of allergy and clinical immunology.
[95] P. Ganz,et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial , 2002, The Lancet.
[96] W. von Scheidt,et al. Vasodilator Response to Nifedipine in Human Coronary Arteries with Endothelial Dysfunction , 2002, Journal of cardiovascular pharmacology.
[97] B. Meiser,et al. Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. , 2001, Journal of the American College of Cardiology.
[98] P. Bongrand,et al. Cytokines and chemokines. , 2001, Cellular and molecular biology.
[99] A. Haverich,et al. Systemic Inflammatory Response in Cardiac Allograft Vasculopathy: High-Sensitive C-Reactive Protein Is Associated With Progressive Luminal Obstruction , 2000, Circulation.
[100] D. Wikler,et al. Early alterations of myocardial blood flow reserve in heart transplant recipients with angiographically normal coronary arteries. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[101] U. Siebert,et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. , 1999, Circulation.
[102] J. Fink,et al. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[103] D. Renlund,et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[104] D. Cooley,et al. Revascularization procedures in patients with transplant coronary artery disease. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[105] M. Yacoub,et al. The prognostic significance of non-invasive cardiac tests in heart transplant recipients. , 1997, European heart journal.
[106] E. Reed,et al. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. , 1996, Transplantation.
[107] D. Renlund,et al. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment. , 1996, Clinical transplantation.
[108] L. Yeatman,et al. Effect of pravastatin on outcomes after cardiac transplantation. , 1995, The New England journal of medicine.
[109] M. Mehra,et al. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. , 1995, The American journal of cardiology.
[110] M. Mehra,et al. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors. , 1994, The American journal of cardiology.
[111] S. Hunt,et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. , 1991, Journal of the American College of Cardiology.
[112] V. Starnes,et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. , 1989, JAMA.
[113] S. Hunt,et al. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. , 1988, The American journal of cardiology.
[114] K. Otsuka,et al. Usefulness of left ventricular diastolic function assessed by magnetic resonance imaging over invasive coronary flow reserve measurement for detecting cardiac allograft vasculopathy in heart transplant recipients , 2012, The International Journal of Cardiovascular Imaging.
[115] M. Reiser,et al. Detection of significant coronary artery stenosis with 64-slice computed tomography in heart transplant recipients: a comparative study with conventional coronary angiography , 2008, The International Journal of Cardiovascular Imaging.
[116] E. Wellnhofer,et al. A decade of percutaneous coronary interventions in cardiac transplant recipients: a monocentric study in 160 patients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[117] Silviu Itescu,et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[118] M. Goddard,et al. Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[119] M. Fishbein,et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[120] V. Velebit,et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. , 1990, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[121] E. Reed,et al. Smooth Muscle Cells: Enhancement by IFN-Transduction in Endothelial Cells and Alloantibody-Mediated Class I Signal , 2022 .